6-OH BAs includes HCA, HDCA, and T-βMCA, which are antagonists of FXR [11], as the ratio of 12-OH BAs to 6-OH BAs increases with aging, implying signaling enhancement of FXR regulation and a potential risk of subsequent metabolic disease and obesity. Here, NR1H4 is linked to obesity disorder.